手术视频
关于我们
联系我们
中心官网
泌尿系统常见疾病循证医学证据
首页
良性前列腺增生
泌尿系统感染
泌尿系统结石
前列腺炎
前列腺癌
膀胱肿瘤
肾癌
其他
首页
搜索结果
证据分类
良性前列腺增生
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
手术视频
调查问卷
泌尿系统感染
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
泌尿系统结石
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺炎
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
膀胱肿瘤
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
肾癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
其他
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
搜索结果
按作者
按标题
按关键词
按摘要
按作者
按期刊
共搜索到
7条
与
Ferro M.
有关的结果
Efficacy of Different Bacillus of Calmette-Guerin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis
2023 年 发布于
Cancers
38 卷 第 12 期
Del Giudice F.
Asero V.
Bologna E.
Scornajenghi C. M.
Carino D.
Dolci V.
Viscuso P.
Salciccia S.
Sciarra A.
D'Andrea D.
Pradere B.
Moschini M.
Mari A.
Albisinni S.
Krajewski W.
Szydelko T.
Malkiewicz B.
Nowak L.
Laukhtina E.
Gallioli A.
Mertens L. S.
Marcq G.
Cimadamore A.
Afferi L.
Soria F.
Mori K.
Tully K. H.
Pichler R.
Ferro M.
Tataru O. S.
Autorino R.
Crivellaro S.
Crocetto F.
Busetto G. M.
Basran S.
Eisenberg M. L.
Chung B. I.
De Berardinis E.
吉西他滨
吡柔比星
非肌层浸润性膀胱癌
膀胱灌注化疗
Meta分析
文献简介
原文链接
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review
2022 年 发布于
Epidemiol Health
24 卷 第 2 期
Barone B.
Calogero A.
Scafuri L.
Ferro M.
Lucarelli G.
Di Zazzo E.
Sicignano E.
Falcone A.
Romano L.
De Luca L.
Oliva F.
Mirto B. F.
Capone F.
Imbimbo C.
Crocetto F.
Carcinoma
Transitional Cell/*pathology/*surgery
Humans
Kidney Neoplasms/*pathology
Neoplasms
Second Primary/*pathology
Nephrotomy
Risk Factors
Stents/*adverse effects
Ureteral Obstruction/etiology/*surgery
Urinary Bladder Neoplasms/*pathology/*surgery
carcinoma
transitional cell
hydronephrosis
meta-analysis
stents
urinary bladder neoplasms
文献简介
原文链接
Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature
2021 年 发布于
PLoS One
49 卷 第 9 期
Crocetto F.
di Zazzo E.
Buonerba C.
Aveta A.
Pandolfo S. D.
Barone B.
Trama F.
Caputo V. F.
Scafuri L.
Ferro M.
Cosimato V.
Fusco F.
Imbimbo C.
Di Lorenzo G.
Bayes Theorem
Cystectomy
Humans
Laparoscopy
Robotic Surgical Procedures
Urinary Bladder Neoplasms/*surgery
文献简介
原文链接
Impact of Smoking Habit on Perioperative Morbidity in Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer: A Systematic Review and Meta-analysis
2021 年 发布于
Prog Urol
39 卷 第 6 期
Tellini R.
Mari A.
Muto G.
Cacciamani G. E.
Ferro M.
Stangl-Kremser J.
Campi R.
Soria F.
Rink M.
Xylinas E.
Minervini A.
Briganti A.
Montorsi F.
Roupret M.
Shariat S. F.
Moschini M.
Metabolic syndrome (MS)
bladder cancer (BC)
grade
meta-analysis
stage
form (available at http://dx.doi.org/10.21037/tcr-20-3350). The authors have no
conflicts of interest to declare.
文献简介
原文链接
Impact of alcohol consumption on the risk of developing bladder cancer: a systematic review and meta-analysis
2019 年 发布于
Medicine
37 卷 第 5 期
Vartolomei M. D.
Iwata T.
Roth B.
Kimura S.
Mathieu R.
Ferro M.
Shariat S. F.
Seitz C.
β-连环蛋白
膀胱癌
病例-对照研究
Meta分析
文献简介
原文链接
Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis
2018 年 发布于
Neurourology and Urodynamics
10 卷 第 5 期
Vartolomei M. D.
Porav-Hodade D.
Ferro M.
Mathieu R.
Abufaraj M.
Foerster B.
Kimura S.
Shariat S. F.
Aged
Blood Loss
Surgical
Cystectomy/*adverse effects/*methods
Female
Humans
Length of Stay
Male
Middle Aged
Operative Time
Postoperative Complications/etiology
Quality of Life
Randomized Controlled Trials as Topic
Robotic Surgical Procedures/*adverse effects/*methods
Treatment Outcome
Urinary Bladder/*surgery
Urinary Bladder Neoplasms/surgery
Urinary Diversion/*adverse effects/*methods
文献简介
原文链接
Systematic Review: Depression and Anxiety Prevalence in Bladder Cancer Patients
2018 年 发布于
Journal of Urology
16 卷 第 1 期
Vartolomei L.
Ferro M.
Mirone V.
Shariat S. F.
Vartolomei M. D.
Administration
Intravesical
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Carcinoma
Transitional Cell/mortality/*pathology/*therapy
Disease Progression
Doxorubicin/administration & dosage/analogs & derivatives
Epirubicin/administration & dosage
Humans
Mitomycin/administration & dosage
Neoplasm Recurrence
Local/*prevention & control
Neoplasm Staging
Randomized Controlled Trials as Topic
Risk Factors
Survival Rate
Thiotepa/administration & dosage
Time Factors
Urinary Bladder Neoplasms/mortality/*pathology/*therapy
Chemotherapy
Meta-analysis
Non–muscle-invasive bladder cancer
Single instillation
Systematic review
文献简介
原文链接